Results of the Phase I Trial of RG7112, a Small-Molecule MDM2 Antagonist in Leukemia.
Clin Cancer Res
; 22(4): 868-76, 2016 Feb 15.
Article
in En
| MEDLINE
| ID: mdl-26459177
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Leukemia, Lymphoid
/
Imidazolines
/
Antineoplastic Agents
Limits:
Humans
Language:
En
Journal:
Clin Cancer Res
Journal subject:
NEOPLASIAS
Year:
2016
Document type:
Article
Country of publication: